Price$127.20+31.45 (+32.85%)
2026-07-162026-10-16
News · 26 weeks43-57%
2026-04-192026-10-11
Mix2590d
- Insider15(60%)
- SEC Filings6(24%)
- Earnings2(8%)
- Dividends1(4%)
- Other1(4%)
Latest news
25 items- SECSEC Form 8-K filed by Mesa Laboratories Inc.8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- PRMesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable GrowthLAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa," "we," "us" or "our"), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced a savings plan (the "Savings Plan") expected to reduce annualized operating costs by approximately $9.3 million. The Savings Plan consists of a global restructuring program (the "Restructuring Program"), a reduction in our San Diego, California facility footprint and reduced third-party spending. We plan to reinvest approximately $4.3 million of the savings into the business to drive profitable growth, for a net annualized cost reduction of approxi
- PRMESA LABS DECLARES QUARTERLY DIVIDENDLakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2026, to shareholders of record at the close of business on November 30, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of critical quality control solutions and life science tools for regulated applications in the pharmaceutical, healthcare and medical device industries. With manufacturing operations in the United States and Europe, and commercial reach
- INSIDERSEC Form 4 filed by Director Capone Mark Christopher4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSEC Form 4 filed by Director Ladiwala Shiraz Shabanali4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSEC Form 4 filed by Director Alltoft Jennifer Sadie4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSEC Form 4 filed by Director Hall Shannon4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSEC Form 4 filed by Director Sullivan John James4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSEC Form 4 filed by Director Tripeny R Tony4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- SECMesa Laboratories Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- INSIDERDirector Capone Mark Christopher converted options into 2,784 shares, increasing direct ownership by 81% to 6,213 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Alltoft Jennifer Sadie converted options into 2,784 shares, increasing direct ownership by 57% to 7,662 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Ladiwala Shiraz Shabanali converted options into 3,810 shares, increasing direct ownership by 45% to 12,333 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Hall Shannon converted options into 2,784 shares, increasing direct ownership by 66% to 6,973 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Tripeny R Tony converted options into 2,784 shares, increasing direct ownership by 44% to 9,082 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Sullivan John James converted options into 2,784 shares, increasing direct ownership by 16% to 20,618 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Sullivan John James sold $800,090 worth of shares (7,093 units at $112.80), decreasing direct ownership by 28% to 17,834 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERPresident and CEO Kadia Siddhartha bought $800,090 worth of shares (7,093 units at $112.80) (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Tripeny R Tony bought $102,321 worth of shares (900 units at $113.69), increasing direct ownership by 17% to 6,298 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- SECSEC Form 10-Q filed by Mesa Laboratories Inc.10-Q - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- SECMesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- PRMesa Labs Announces First Quarter ResultsLAKEWOOD, Colo., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter ("1Q27") ended June 30, 2026 (amounts in thousands). 1Q27 Financial Summary – (comparisons are versus the same prior year period) Revenues increased 1.0%Non-GAAP organic and core organic revenues1 growth was 1.0% and 0.4%, respectivelyOperating income increased 129% to $7,031Non-GAAP adjusted operating income ("AOI") excluding unusual items2 increased 19.5% and was 25.6% as a percentage of revenuesRepaid $8,656
- PRMesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference CallLAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced it will release financial results for its first fiscal quarter ("1Q27") ended June 30, 2026 following market close on Monday, August 10, 2026. The Company will also hold its first earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts. Details for the conference call can be found below: Date:Monday, August 10, 2026Time:4:30 p
- SECMesa Laboratories Inc. filed SEC Form 8-K: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements and Exhibits8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- SECSEC Form DEF 14A filed by Mesa Laboratories Inc.DEF 14A - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
MLAB FAQ
7 questionsWhat does Mesa Laboratories Inc. do?
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment...Where does MLAB stock trade?
Mesa Laboratories Inc. (MLAB) is listed on NASDAQ.What sector and industry is MLAB in?
Mesa Laboratories Inc. operates in the Industrials sector, Industrial Machinery/Components industry.Does MLAB pay a dividend?
Yes. MLAB's next ex-dividend date is 2026-11-30 with a declared cash dividend of $0.16 per share, payable 2026-12-15.What are analysts saying about MLAB?
Mesa Laboratories Inc. has had 3 recent analyst actions on file. The most recent action was from Wells Fargo: Equal Weight on 2025-08-07.What companies are similar to MLAB?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare MLAB side-by-side with any of them on Quantisnow.How can I track MLAB on Quantisnow?
Quantisnow aggregates Mesa Laboratories Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MLAB to receive live email and push alerts on every new disclosure.